185 related articles for article (PubMed ID: 29180877)
1. Clinical significance of CMTM4 expression in hepatocellular carcinoma.
Bei C; Zhang Y; Wei R; Zhu X; Wang Z; Zeng W; Chen Q; Tan S
Onco Targets Ther; 2017; 10():5439-5443. PubMed ID: 29180877
[TBL] [Abstract][Full Text] [Related]
2. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma.
Tan S; Guo X; Bei C; Zhang H; Li D; Zhu X; Tan H
BMC Cancer; 2022 Aug; 22(1):905. PubMed ID: 35986302
[TBL] [Abstract][Full Text] [Related]
4.
Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Chui NN; Cheu JW; Yuen VW; Chiu DK; Goh CC; Lee D; Zhang MS; Ng IO; Wong CC
Hepatol Commun; 2022 Jan; 6(1):178-193. PubMed ID: 34558800
[TBL] [Abstract][Full Text] [Related]
6. CMTM4 inhibits cell proliferation and migration via AKT, ERK1/2, and STAT3 pathway in colorectal cancer.
Xue H; Li T; Wang P; Mo X; Zhang H; Ding S; Ma D; Lv W; Zhang J; Han W
Acta Biochim Biophys Sin (Shanghai); 2019 Sep; 51(9):915-924. PubMed ID: 31435638
[TBL] [Abstract][Full Text] [Related]
7. Expression of CMTM4 shows clinical significance in lung cancer.
Zhu X; Zhang S; Tan S; Li D; Chen X; Kong J; Fu Y; Wang C; Wen L
Transl Cancer Res; 2020 Oct; 9(10):6214-6220. PubMed ID: 35117232
[TBL] [Abstract][Full Text] [Related]
8. Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.
Li M; Luo F; Tian X; Yin S; Zhou L; Zheng S
Front Oncol; 2020; 10():595973. PubMed ID: 33282744
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of RKIP, TGM2, and CMTM4 expression in oral squamous cell carcinoma.
Luo T; Xu T; Ou Y; Ci H; Sun J
Medicine (Baltimore); 2024 Feb; 103(7):e37278. PubMed ID: 38363884
[TBL] [Abstract][Full Text] [Related]
10. Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma.
Zhu X; Qi G; Li C; Bei C; Tan C; Zhang Y; Shi W; Zeng W; Kong J; Fu Y; Tan S
DNA Cell Biol; 2019 Feb; 38(2):193-197. PubMed ID: 30562063
[TBL] [Abstract][Full Text] [Related]
11. Integrated Analyses of Phenotype and Quantitative Proteome of CMTM4 Deficient Mice Reveal Its Association with Male Fertility.
Liu F; Liu X; Liu X; Li T; Zhu P; Liu Z; Xue H; Wang W; Yang X; Liu J; Han W
Mol Cell Proteomics; 2019 Jun; 18(6):1070-1084. PubMed ID: 30867229
[TBL] [Abstract][Full Text] [Related]
12. Downregulated CMTM2 Poses Potential Clinical Significance in Hepatocellular Carcinoma.
Guo X; Zhang S; Tan S; Bei C; Zhang H; Zhu X; Qiu X
DNA Cell Biol; 2020 Apr; 39(4):683-689. PubMed ID: 31990600
[TBL] [Abstract][Full Text] [Related]
13. [Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors].
Xie G; Cheng J; Zhang J
Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):46-51. PubMed ID: 36792080
[TBL] [Abstract][Full Text] [Related]
14. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
[TBL] [Abstract][Full Text] [Related]
15. Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
Duan HJ; Li XY; Liu C; Deng XL
Chin Med J (Engl); 2020 Apr; 133(8):951-958. PubMed ID: 32195671
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer.
Liang Z; Xie J; Huang L; Huang Y; Zhang Y; Ma R; Zheng Z; Wang Q; Li X
J Gastrointest Oncol; 2021 Apr; 12(2):388-406. PubMed ID: 34012634
[TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of CMTM1 in hepatocellular carcinoma.
Song X; Zhang S; Tian R; Zheng C; Xu Y; Wang T; Bei C; Zhang H; He X; Zhu X; Tan S
Open Med (Wars); 2021; 16(1):217-223. PubMed ID: 33585698
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
19. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
Wu J
Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
[TBL] [Abstract][Full Text] [Related]
20. CMTM6 and CMTM4 as two novel regulators of PD-L1 modulate the tumor microenvironment.
Zhang T; Yu H; Dai X; Zhang X
Front Immunol; 2022; 13():971428. PubMed ID: 35958549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
